Thus, researchers must describe the outcomes of COVID-19 in patients with CF with different genetic profiles, like in the case of Brazil, where rare and new genetic variants in the CFTR gene were previously described [57,58,59,60]. The gene discussed is CFTR; the disease is cystic fibrosis.